Biotech Values

[biomaven0]

I could well see Teva electing to keep its processing and characterization technology as a trade secret. Any patents in this area would be very hard to enforce anyhow (as Momenta is likely to find even if Teva was in fact infringing).

So I really don't see the absence of patents or publications as much evidence of absence of capability here.

Peter